Henry Hess | Chief Legal Counsel |
Irene McCarthy | President, CEO, Secretary & Director |
James Carr | Chief Clinical Development Officer |
Brian Blakey | Chief Business Officer |
Robert Weiskopf | CFO |
Marty Redmon | Chief Research & Development Officer |
Yi Chen | H.C. Wainwright & Co. |
Greetings, and welcome to the Stealth BioTherapeutics Q2 Earnings Conference Call. [Operator Instructions].
As a reminder, this conference is being recorded Thursday, August 5, 2021. I would now like to turn the conference over to Henry Hess, Chief Legal Counsel. Please go ahead.